Welcome to the new RCOphth website

Find out more about our brand new website.

X

News & Views

Read the latest RCOphth news updates and guidance here.

Statement

NICE guidance on Ocriplasmin

The Royal College of Ophthalmologists welcomes the decision by the National Institute for Health and Care Excellence (NICE) to recommend 125 micrograms Ocriplasmin intravitreal injection as an option for the treatment of vitreomacular traction (VMT) in adults who have either stage II full-thickness macular holes (FTMH) with a diameter of ≤ 400um and/or severe symptoms.